CRIZANLIZUMAB-TMCA vs CRIZOTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CRIZANLIZUMAB-TMCA vs CRIZOTINIB: Safety Overview
| Metric | CRIZANLIZUMAB-TMCA | CRIZOTINIB |
|---|---|---|
| Total FAERS Reports | 1,130 | 9,948 |
| Deaths Reported | 37 | 3,173 |
| Death Rate | 3.3% | 31.9% |
| Hospitalizations | 435 | 2,520 |
| Average Patient Age | 29.9 yrs | 58.5 yrs |
| % Female Patients | 63.6% | 55.2% |
| FDA Approval Date | N/A | Aug 26, 2011 |
| Manufacturer | N/A | Pfizer Laboratories Div Pfizer Inc |
| Route | N/A | ORAL |
| Marketing Status | Prescription | Prescription |